AOTMiT: The Transparency Council will evaluate drugs, benefits and health programs

During the session, preparation was planned:

1. Positions on the qualification of the service "Repositioning and immobilization of a dislocated tooth or group of teeth and removal of a dental splint when replacing or completing treatment" as a guaranteed benefit.
2. Positions on the evaluation of the drug Keytruda (pembrolizumabum) under the drug program "Treatment of patients with cervical cancer (ICD-10: C53)".
3. Opinion on the inclusion in reimbursement of drugs containing the active substance tacrolimus in the off-label indication: Henoch-Schoenlein syndrome (IgA-induced vasculitis, IgA-vasculitis) in case of intolerance, contraindications or resistance to other treatments.
4. Opinion on the inclusion in reimbursement of drugs containing the active substance tacrolimus in off-label indications:

• Steroid-dependent nephrotic syndrome/steroid-resistant nephrotic syndrome/recurrent n ephrotic syndrome - in case of cyclosporine intolerance or cyclosporine resistance,
• Lupus nephropathy/lupus nephritis - in case of intolerance, contraindication or resistance to other treatments.

1. Opinion on the inclusion in reimbursement of drugs containing the active substance letermovir in the off-label indication: the use of letermovir to prevent reactivation of cytomegalovirus (CMV) and the development of the disease in children before the age of 18 years, seropositive to CMV, who have undergone allogeneic hematopoietic stem cell transplantation.
2. Opinion on the draft health policy program of the local government unit "Support for infertility treatment by in vitro fertilization - in vitro for residents of Kluczbork municipality in 2024-2026".
3. Opinion on the draft health policy program of the local government unit "Obesity prevention program among the adult population of residents of the Lublin region for 2023-2028".
4. Opinion on the draft health policy program of the local government unit "Type 2 diabetes prevention program for residents of Długołęka aged 45-64 years for 2024-2026".
5. Opinion on the draft health policy program of the local government unit "Healthy mother - healthy child"

Source: AOTMiT